-
$60M Challenge Seeks RNA Bio-Production Network
A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products.
-
Precision Gene-Editing Biotech Gains $200M in New Funds
A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections.
-
Trial Underway for Crispr Lymphoma Therapy
A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr.
-
Infographic – U.S. Leads Record Q2 Venture Funding
Venture capital financing broke global records in the second quarter of 2021, with investments in the U.S. accounting for nearly half of all dollars invested.
-
Neuro Disease Start-Up Raises $73M in Early Funds
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round.
-
Fitness Tracker Data Show Longer Covid-19 Effects
Data collected from wearable activity trackers show extended cardiac effects in people with Covid-19 infections, in some cases for several months.
-
Univ. Lab Testing Wearable Respiratory Monitor
Medical researchers are assessing the feasibility of a wearable device to detect advance indicators of chronic respiratory disease symptoms.
-
Trial Underway Testing Suicide-Prevention Nasal Spray
A clinical trial testing a nasal spray against a placebo to prevent suicide from depression enrolled its first participants considered at high risk of suicide.
-
3-D Printed Scaffold Helps Regrow Soft Tissue
Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth.
-
Infographic – Biotech Index Rebounds in Q2
Since mid-May, NBI rose steadily, closing at 5,148 by the end of June, a gain of nine percent for the quarter and eight percent for the year.